Please help us continue educating the public about herpes and cold sores
MAKE A DONATIONSPEAK TO A COUNSELLOR (weekdays 9am-5pm)
Tollfree from a landline: 0508 11 12 13
From a mobile: 09 433 6526
SUPPORT OUR MISSION
TO EDUCATE
DONATE NOW
Oral antiviral medication can improve your quality of life, give you a feeling of control, and physical and mental relief from experiencing recurrences of herpes.
Knowing about the treatment options provides you with information to have an open and informed discussion with your health professional about what is best for you.
The following treatments may alleviate the pain and discomfort of genital sores.
For anyone who is experiencing extreme pain when urinating, sitting in a warm bath or using a pump bottle full of water and spraying water on yourself can make the process less painful. It is extremely important to drink plenty of fluids as this dilates the urine. A conversation with your health professional is required if your pain is severe or you are experiencing nerve pain as additional medical therapy may be indicated.
The standard, effective and specific treatment for genital herpes is antiviral therapy, which is usually in tablet form. Antiviral drugs work by stopping HSV from replicating in the body. The antiviral drug only works in body cells where the herpes virus is present, therefore making the drug safe and unlikely to cause side effects. The treatment only works while you are taking the drug and cannot prevent future outbreaks once you stop taking it.
Antiviral treatments can:
Antiviral medications can be used in two ways:
Episodic treatment is taking a short course of valaciclovir at the onset of a recurrence. Those who have less frequent recurrences may find episodic treatment useful. It works best if treatment is taken as soon as warning signs of an impending recurrence (such as neuralgic pain and/or tingling or buzzing sensation in the skin), occur. If taken soon enough, it may stop ulcers developing. It helps to have valaciclovir available beforehand. If you want to use episodic treatment, ask your health care professional to prescribe a supply for you, so you can start the treatment as soon as you feel the symptoms start. As soon as you get the ‘warning’ signs of a herpes recurrence, take valaciclovir 500mg twice daily for 3 days.
Ask your health care professional to provide a prescription of 48 x 500mg valaciclovir tablets so you can self-initiate treatment at the onset of symptoms.
This approach will not have any effect on asymptomatic viral shedding and hence its effect on reducing transmission is not likely to be very significant. Episodic treatment is useful, however, for people who have infrequent attacks or for when people are stopping continuous suppressive therapy.
General practitioners/nurse practitioners are able to prescribe oral antivirals for suppressing herpes. Prescriptions can be filled at retail pharmacies. An increasing number of pharmacists are able to supply an episodic course of antiviral medication for people with a recurrence of facial or genital herpes which may be helpful in situations where patients are unable to access timely appointments with their healthcare provider.
Suppressive therapy involves taking an oral antiviral drug every day for prolonged periods. It interferes with the virus reproductive cycle and so prevents or dramatically reduces the number of recurrences. When recurrences do occur, they are usually less severe and shorter lasting.
Studies have proven that continuous suppressive antiviral therapy can dramatically reduce the frequency of outbreaks, or prevent them altogether, and reduces the risk of asymptomatic shedding, normally 2% to 5% of days per year, by 75%. For example, a very large study found that people who had an average of over 12 occurrences a year, could reduce the frequency of their outbreaks to less than two a year after one year of continuous suppressive therapy.
The study also showed that if recurrences do occur during suppressive therapy, they are usually less severe and shorter lasting.
Taking suppressive therapy, even for a short time, may help you break the cycle and give you a sense of control over the infection.
Suppressive antiviral therapy is suitable for you if any of the following applies to you:
Valaciclovir is the recommended treatment for suppressive therapy in New Zealand. It is a prodrug of aciclovir, meaning that it is converted into aciclovir in the body. Valaciclovir has better absorption, allowing for slower breakdown and less frequent dosing compared to aciclovir, making it more convenient for long-term suppressive therapy.
Suppressive therapy is taken continuously, i.e. daily, for months or even years.
Suppressive antiviral therapy has also been shown to reduce viral shedding between episodes and therefore may help reduce the risk of transmitting the virus to sexual partners. Asymptomatic shedding occurs 2 to 5% days per year. Studies have shown suppressive treatment with valaciclovir reduces transmission of asymptomatic herpes by 75% so nearly eliminating the risk of transmission. Valaciclovir tablets are the recommended treatment for herpes in New Zealand.
Valaciclovir, which is available fully subsidised by prescription, is very safe and effective, even when taken for long periods of time.
For people experiencing the initial or primary episode, a course of valaciclovir tablets can markedly reduce the duration of the episode and give effective relief from symptoms.
Valaciclovir does not eliminate the herpes virus from the body and therefore a course of valaciclovir will not provide a “cure”, but assists in the management of the infection.
If you choose suppressive therapy, you do not have to stay on it permanently. If you prefer, you can take it until you feel in control of the infection, but this is usually a period of 12 months initially. Your health care professional may suggest you stop the suppressive therapy for a period that is sufficient to establish whether the pattern of recurrence has changed or at least 2 recurrences, in order to assess how active your genital herpes remains. If you are still having problems with recurrences, you and your health care professional may then decide that you should start suppressive therapy again.
Valaciclovir has been reported to cause no serious side-effects, even after years of use. A few people taking suppressive therapy do experience minor side-effects such as headache, nausea and diarrhoea. If you have a problem, discuss this with your health care professional. Research to date shows that people with normal immune systems who are on oral antivirals for a long period do not develop virus resistance or clinical breakthrough. Also, there is little interaction with other drugs, e.g. the contraceptive pill is unaffected by valaciclovir or aciclovir.
Suppressive therapy may give marked improvement to your emotional well-being. Many people find the fact that they can control the infection gives a boost to their sense of well-being and self-confidence. Even if only taken for a few months, suppressive therapy can help you to come to terms with emotions caused by recurrent genital herpes, including depression and anxiety. Make sure that you continue to talk to a health professional you are comfortable with, at least until you feel completely at ease with having genital herpes.
Recent studies using an HSV-2 vaccine are showing some promise in both prevention and transmission of HSV-2. However, these are still in the developmental research stage and will not be available commercially for some years.
Many people find that having a healthy diet, eating regularly and eating enough sleep are helpful in preventing recurrences see our page on complementary treatments.
Oral antiviral tablets are not routinely recommended for use during pregnancy. However, valaciclovir/aciclovir have been used for treating genital herpes for over 40 years and as with any drug, a register has been kept to report any adverse side effects for pregnant people who have taken it. To date there have been no adverse side effects reported for either the baby or the parent.
Due to the potential seriousness of a primary episode of genital herpes for the baby and the relative safety of valaciclovir/aciclovir, it is now recommended that valaciclovir/aciclovir are used for treating a first episode of genital herpes or severe recurrent herpes in the last trimester of pregnancy. It is believed that the benefit of using valaciclovir/aciclovir, by reducing the risk of transmission of herpes to the baby, outweighs the risk of not using it.
Topical antiviral creams are available over the counter but are no longer subsidised on the pharmaceutical schedule and are not recommended as a treatment for first episode or recurrent genital herpes as they are of little benefit.
If you have just found out that you have genital herpes, it is likely that you will have a lot of questions.
A diagnosis of genital herpes often comes as a shock. Adequate information about genital herpes and the implications for the future are an important part of the initial treatment. Counselling offers a way of dealing with any concerns you may have.
Our Herpes Helpline has a specialist nurse counsellor who will be able to provide support and education around a herpes diagnosis. The Helpline is open 9am to 5pm on weekdays if you would like to speak to one of our nurse counsellors. Phone 0508 11 12 13 toll free from a landline, or 09 433 6526 from a mobile. Alternatively you can email your questions through to [email protected].
The experience and support of other people with herpes can be extremely valuable for some. However, NZHF will not recommend any support groups as we cannot guarantee that they will always offer safe, accurate, or appropriate information.
This website is brought to you by the Sexually Transmitted Infections Education Foundation (STIEF) - an initiative funded by Te Whatu Ora.
The medical information in this website is based on the STIEF Guidelines for the Management of Genital Herpes in New Zealand. The New Zealand Ministry of Health supports the use of these clinical guidelines, developed by clinical experts and professional associations to guide clinical care in New Zealand.
The Guidelines are produced by considering available literature, both New Zealand wide and international, and by basing the medical recommendations on the evidence in the literature or reasonable supposition and opinions of medical experts.
NZHF is a registered charitable organisation. Our Charities Commission registration number is CC11276.
From a landline (tollfree): 0508 11 12 13
From a mobile: 09 433 6526
Email: [email protected]
NZ Herpes Foundation
C/- Sexually Transmitted Infections Education Foundation (STIEF)
CPO Box 2437, Shortland Street, Auckland 1140
New Zealand
© Copyright
2024 New Zealand Herpes Foundation. All rights reserved.
Disclaimer / Security / Privacy
Website&SEObyOriginal Image